Cite
MLA Citation
L. Cabel et al.. “371 Potential benefit of pharmacokinetically-guided dosing strategy for the decision making in cancer patients treated with sunitinib.” European journal of cancer, vol. 51, n.d., pp. S78–. http://access.bl.uk/ark:/81055/vdc_100030628020.0x00002b